Observational studyEmerging microbes & infections2020
Long-term follow-up of
Observational study in Emerging microbes & infections, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Gastric cancer prevention byFrontiers in oncology · 2026Pooled it
- Health education based on precede-proceed model in eradication evaluation of Helicobacter pylori infection: a retrospective cohort study.BMC gastroenterology · 2025Trial
- Breaking the time barrier in Helicobacter pylori retreatment: Insights from multidimensional perspectives.Chinese medical journal · 2026Article
- Barriers toBMJ open · 2026Article
- Predicting patient dropout: a nomogram for loss to follow-up afterFrontiers in public health · 2026Article
- Assessment of treatment effectiveness, follow-up results, and recurrence patterns in children withFrontiers in pediatrics · 2026Article
- WeChat-based manual enhanced guidance in patients with Helicobacter pylori infection.BMC gastroenterology · 2025Article
- Review
- Review
- Association of long-term use of low-dose aspirin with Helicobacter pylori infection and effect on recurrence rate.Scientific reports · 2024Article
- Sex differences in Helicobacter pylori infection and recurrence rate among 81,754 Chinese adults: a cross-sectional study.BMC gastroenterology · 2024Article
- 'Family-based' strategy forGut · 2024Article
- Helicobacter pylori Eradication Treatment in Older Patients.Drugs & aging · 2024Review
- Success of susceptibility-guided eradication ofWorld journal of gastroenterology · 2024Article
- Cost-effectiveness analysis of Anaprazole versus Ilaprazole for the treatment of duodenal ulcers in China.Frontiers in pharmacology · 2024Article
- Controlling Gastric Cancer in a World of Heterogeneous Risk.Gastroenterology · 2023Review
- Controlling the Impact ofMedicina (Kaunas, Lithuania) · 2023Article
- Antibiotic Resistance ofJournal of clinical medicine · 2023Article
- Short-term outcomes and intermediate-term follow-up ofBMJ open · 2022Observational
- Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis.Helicobacter · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.